• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.

作者信息

Morfini M, Longo G, Matucci M, Vannini S, Messori A, Filimberti E, Duminuco M, Avanzi G, Rossi-Ferrini P

出版信息

Ric Clin Lab. 1984 Oct-Dec;14(4):681-91. doi: 10.1007/BF02906309.

DOI:10.1007/BF02906309
PMID:6441235
Abstract

In vitro and in vivo characteristics of cryoprecipitates and three commercial factor VIII concentrates (Kryobulin, Hemofil and Koate) were comparatively studied. Factor VIII:C/VIIIR:Ag ratio was very low in all commercial concentrates without differences among them. Conversely, the decrease of factor VIIIR:WFRCof was proportional to the degree of purity. Factor VIII:C/VIIIR:WFRCof ratio was shown to be a reliable index of factor VIII complex denaturation. Crossed electroimmunoassay showed a faster migration of factor VIIIR:Ag only in commercial concentrates. Using a two-compartmental open model that accounts for endogenous synthesis of factor VIII:C, single-dose kinetics of factor VIII:C were studied in 23 patients with classic hemophilia. Good agreement between measured and fitted values of factor VIII:C plasma concentration was observed. beta half-life was shorter in high purity concentrates and longer in intermediate purity concentrates and cryoprecipitates.

摘要

相似文献

1
Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
Ric Clin Lab. 1984 Oct-Dec;14(4):681-91. doi: 10.1007/BF02906309.
2
Characteristics of the factor VIII protein and Factor XIII in various factor VIII concentrates.各种凝血因子 VIII 浓缩物中凝血因子 VIII 蛋白和凝血因子 XIII 的特性
Scand J Haematol. 1980 Apr;24(4):340-9. doi: 10.1111/j.1600-0609.1980.tb01593.x.
3
Factor VIII complex in myelomatosis and related disorders.骨髓瘤及相关疾病中的凝血因子VIII复合物
Ric Clin Lab. 1982 Oct-Dec;12(4):581-8. doi: 10.1007/BF02909343.
4
Specific factor VIII-related antigen fragmentation: an in vivo and in vitro phenomenon.特定的凝血因子 VIII 相关抗原片段化:一种体内和体外现象。
Blood. 1982 Oct;60(4):930-9.
5
Biochemical and in vivo properties of commercial virus-inactivated factor VIII concentrates.市售病毒灭活凝血因子VIII浓缩物的生化特性及体内特性
Eur J Haematol. 1988 Mar;40(3):205-14. doi: 10.1111/j.1600-0609.1988.tb00825.x.
6
Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.正常人和血管性血友病患者中凝血因子VIII促凝抗原及因子VIII相关抗原的凝胶过滤模式
Thromb Haemost. 1983 Aug 30;50(2):509-12.
7
Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.新生儿脐带血中的凝血因子VIII促凝活性、凝血因子VIII相关抗原及血管性血友病因子
Br J Haematol. 1979 Aug;42(4):637-46. doi: 10.1111/j.1365-2141.1979.tb01176.x.
8
Effect of virucidal heat treatment on proteins in human factor VIII concentrates.
Transfusion. 1988 Jan-Feb;28(1):8-13. doi: 10.1046/j.1537-2995.1988.28188127962.x.
9
[Factor VIII complex activities in acute leukemia].[急性白血病中的凝血因子 VIII 复合物活性]
Acta Haematol Pol. 1980 Oct-Nov;11(4):239-47.
10
Purification of the factor VIII complex.凝血因子 VIII 复合物的纯化。
Thromb Res. 1984 Aug 15;35(4):431-50. doi: 10.1016/0049-3848(84)90235-4.

引用本文的文献

1
The History of Clotting Factor Concentrates Pharmacokinetics.凝血因子浓缩物药代动力学的历史
J Clin Med. 2017 Mar 20;6(3):35. doi: 10.3390/jcm6030035.
2
Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.
Clin Pharmacokinet. 1987 Dec;13(6):365-80. doi: 10.2165/00003088-198713060-00002.